Cantor Fitzgerald holds a conference call with CEO Cohen to discuss CB1 on August 9 at 12 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBP:
- Corbus Pharmaceuticals price target raised to $88 from $80 at Oppenheimer
- Corbus Pharmaceuticals Shares Updated Corporate Presentation
- Corbus Pharmaceuticals Shares Operational Insights with SEC
- Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
- Corbus Pharmaceuticals reports Q2 EPS (90c), consensus ($1.19)